Cargando…
HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
OBJECTIVE: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally. RES...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580609/ https://www.ncbi.nlm.nih.gov/pubmed/31208438 http://dx.doi.org/10.1186/s13104-019-4375-0 |
_version_ | 1783428054456991744 |
---|---|
author | Lumngwena, Evelyn Ngwa Shuping, Liliwe Bernitz, Netanya Woodman, Zenda |
author_facet | Lumngwena, Evelyn Ngwa Shuping, Liliwe Bernitz, Netanya Woodman, Zenda |
author_sort | Lumngwena, Evelyn Ngwa |
collection | PubMed |
description | OBJECTIVE: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally. RESULTS: We deleted five PNGs previously linked to HIV-1 transmission of two matched Envelope clones representing variants at 5 and 173 weeks post-infection. The transmitted founder (TF) had significantly better pseudovirus entry efficiency than the chronic infection (CI) variant. Deletion of all PNGs significantly reduced TF entry efficiency, binding to dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN) receptor and trans-infection. However, mutational analysis did not affect the phenotype of the CI Envelope to the same extent. Notably, deletion of the PNGs at N241 and N448 had no effect on CI Envelope function, suggesting that some PNGs might only be important during acute infection. Therefore, vaccines that elicit antibodies against N-glycans important for TF Envelope function could drive the loss of PNGs during immune escape, abrogating viral replication. Conversely, changes in N-glycosylation might have no effect on some variants, reducing vaccine efficacy. This finding highlights the need for further investigation into the role of Envelope N-glycosylation in HIV-1 pathogenesis. |
format | Online Article Text |
id | pubmed-6580609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65806092019-06-24 HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression Lumngwena, Evelyn Ngwa Shuping, Liliwe Bernitz, Netanya Woodman, Zenda BMC Res Notes Research Note OBJECTIVE: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally. RESULTS: We deleted five PNGs previously linked to HIV-1 transmission of two matched Envelope clones representing variants at 5 and 173 weeks post-infection. The transmitted founder (TF) had significantly better pseudovirus entry efficiency than the chronic infection (CI) variant. Deletion of all PNGs significantly reduced TF entry efficiency, binding to dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN) receptor and trans-infection. However, mutational analysis did not affect the phenotype of the CI Envelope to the same extent. Notably, deletion of the PNGs at N241 and N448 had no effect on CI Envelope function, suggesting that some PNGs might only be important during acute infection. Therefore, vaccines that elicit antibodies against N-glycans important for TF Envelope function could drive the loss of PNGs during immune escape, abrogating viral replication. Conversely, changes in N-glycosylation might have no effect on some variants, reducing vaccine efficacy. This finding highlights the need for further investigation into the role of Envelope N-glycosylation in HIV-1 pathogenesis. BioMed Central 2019-06-17 /pmc/articles/PMC6580609/ /pubmed/31208438 http://dx.doi.org/10.1186/s13104-019-4375-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Note Lumngwena, Evelyn Ngwa Shuping, Liliwe Bernitz, Netanya Woodman, Zenda HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression |
title | HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression |
title_full | HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression |
title_fullStr | HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression |
title_full_unstemmed | HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression |
title_short | HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression |
title_sort | hiv-1 subtype c envelope function becomes less sensitive to n-glycosylation deletion during disease progression |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580609/ https://www.ncbi.nlm.nih.gov/pubmed/31208438 http://dx.doi.org/10.1186/s13104-019-4375-0 |
work_keys_str_mv | AT lumngwenaevelynngwa hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression AT shupingliliwe hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression AT bernitznetanya hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression AT woodmanzenda hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression |